Clinical trial
Clinical Evidence-based Evaluation of the Efficacy of Shenbai Granules in Preventing Recurrent Colorectal Adenomas After Polypectomy and Its Therapeutic Mechanism
NCT03616444 is registered in ClinicalTrials.gov with Jiangsu Famous Medical Technology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Clinical Evidence-based Evaluation of the Efficacy of Shenbai Granules in Preventing Recurrent Colorectal Adenomas After Polypectomy and Its Therapeutic Mechanism
- Lead sponsor
- Jiangsu Famous Medical Technology Co., Ltd.
- Phase
- Phase 2/3
- Overall status
- Completed
- Start date
- December 3, 2018
- Completion date
- June 28, 2023
- Enrollment
- 400 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastroenterology